The U.S. Food and Drug administration (FDA) has approved several polyclonal antibody preparations and at least 18 monoclonal antibody preparations (antibodies, antibody fragments, antibody fusion proteins, etc.). These drugs, which may be considered as a diverse group of therapeutic proteins, are as
Pharmacokinetics and pharmacodynamics of ketoprofen plasters
β Scribed by Sung-Koun Heo; Jeiwon Cho; Ji-Woong Cheon; Min-Koo Choi; Dong-Soon Im; Jung Ju Kim; Yang Gyu Choi; Do Yong Jeon; Suk-Jae Chung; Chang-Koo Shim; Dae-Duk Kim
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 134 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.587
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics and pharmacodynamics of levodopa are dominated by two features: the short plasma half-life of the drug and the portion of the antiparkinsonian response that parallels the plasma levodopa levels, the socalled short-duration response. These features are the basis of motor fluctuat
## Abstract The pharmacokinetic profile of ketoprofen suppositories following single and chronic (32 doses) administration to 12 healthy adult male volunteers was established. Each subject received a single rectal dose of 100 mg of ketoprofen on day 1, followed by one suppository of 100 mg b.i.d. f
This study determined the kinetics of the effects of atropine on heart rate and saliva flow in three healthy male volunteers after intravenous administration of 1.35 and 2.15 mg of the drug. The pharmacokinetics of atropine and its primary metabolite, tropine, were determined simultaneously. Both th
The pharmacokinetics and pharmacodynamics of trimazosin are described following both intravenous and oral administration to 6 normotensive, male volunteers. The IV and oral drug and metabolite (l-hydroxytrimazosin) concentration data are fitted simultaneously to the same pharmacokinetic model. The p